Comunicati.net - Comunicati pubblicati - Tecnologia Comunicati.net - Comunicati pubblicati - Tecnologia Thu, 28 May 2020 00:31:45 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://zend.comunicati.net/comunicati/aziende/tecnologia/1 APAC Respiratory Devices Market size Analysis Size Influencing Trends 2023 Tue, 26 May 2020 23:20:52 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640773.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640773.html Market Research Future Market Research Future Market Research Future published a research report on APAC Respiratory Devices Market size. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

 

APAC Respiratory Devices Market size information, By Devices (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, Gas Analyzers, Capnographs, positive airway pressure (PAP), and others), by technology (Electrostatic Filtration, HEPA Filter, Hollow Fiber Filtration, Microsphere Separation and others) and by end user (Hospital and Homecare) -Forecast to 2023

Market Scenario:

Respiratory therapeutic devices are the instrument or the devices used to treat the respiratory diseases. These therapeutic devices are used in the treatment of chronic and acute respiratory diseases such as Asthma, COPD, tuberculosis and many more. Respiratory devices market is continuously growing in Asia Pacific region due to increasing number of cases of respiratory problems and is expected to growing with a healthy rate of ~9.5%. Increasing population has increased the pollution and different air borne disease which has serve as a driving factor for the increase in the respiratory therapeutic devices market.

Regional Analysis

On regional basis Asia Pacific is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific. Increasing prevalence of diseases has increased the respiratory therapeutic device market. According to COPD foundation, it was estimated that 6.2% of total Asia Pacific population is suffering from COPD. And COPD will be the fifth leading cause for death till 2020. India has 30 million COPD patient while 8% of total china population is suffering from COPD due to increasing pollution.

Segments:

Asia Pacific Respiratory Therapeutic Devices market has been segmented on the basis of-

  • By types of respiratory therapeutic devices used which includes- Nebulizers [Mechanical Nebulizer (Soft mist inhaler, Human powered nebulizer) and Electrical Nebulizer (Jet nebulizer, Ultrasonic wave Nebulizer and Other), Humidifiers (Bubble Humidifiers and Electrical Humidifier), Oxygen Concentrators (Continues Oxygen Concentrators and Portable Oxygen Concentrators), Ventilators (Volume-cycled ventilators, Pressure-cycled ventilators, Flow-cycled ventilators and other), Gas Analyzers, Capnographs, Positive airway pressure (Continuous Positive airway pressure, Automatic Positive airway pressure and Other ), Masks (Nasal Mask, Full Face Mask and Other) and others devices
  • By technology used which includes Electrostatic Filtration, HEPA Filter, Hollow Fiber Filtration, Microsphere Separation and others
  • By end user they are Hospital and Homecare
  • By Countries they are Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Anal Cancer Market size Analysis 2020 Global Trends, Size, Opportunities, Sales Revenue Tue, 26 May 2020 23:10:47 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640771.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640771.html Market Research Future Market Research Future Leading Market Manufacturers

Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene Corporation (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson Services, Inc. (US) and Hospira, Inc. (US)

Global Anal Cancer Market size Research Report: Information by Cancer Type (Carcinoma in Situ, Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Melanoma and others), Treatment Type (Chemotherapy, Surgery, Radiation Therapy and Immunotherapy), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025,Confirms MRFR

Anal Cancer Market Overview

Anal cancer is cancer of the anus or the surrounding area. Anal cancer can be caused by all of the regular causes of cancer, i.e. smoking, chewing tobacco, radiation poisoning, etc., but can also be caused by the HPV virus. In fact, HPV accounts for more than 90% of all anal cancers, making it a closely associated pathogen. Anal cancer is rarely found in younger demographics, with people above 60 being the prime candidate for the disease. It is estimated to cause more than 8,000 new cases in the U.S. in 2019, accompanied by more than a thousand deaths. The five-year survival rate for anal cancer is 66%, a considerable improvement upon some other types of cancer but worrying nevertheless.

Segmentation:

Global anal cancer market has been segmented on the basis of type into squamous cell carcinoma, adenocarcinoma, perianal skin cancer, melanoma, and others.

On the basis of treatment, the global anal cancer market is segmented into chemotherapy, radio therapy, surgery, and others.

On the basis of end user, the global anal cancer market is segmented into hospitals, clinics, research institutes, and others.

Key Questions Answered in This Report:

  • What will the market size and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

Industry/Innovation/Related News:

November 30, 2018 – A research group at the University of Alabama (US), published their findings of the study they carried out for the treatments and vaccinations that can be repurposed for HPVs. Preclinical experiments indicate towards the cancer drugs vorinostat, belinostat and panobinostat that can be repurposed to treat infections caused by human papillomaviruses, or HPV.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Microelectronic Medical Implants Market 2020 Share Report Analysis, Technology Advancement, Top Companies Tue, 26 May 2020 23:00:24 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640770.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640770.html Market Research Future Market Research Future Market Research Future published a research report on Microelectronic Medical Implants Market Research Report - Global Forecast To 2022 Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

The Microelectronic Medical Implants Market share is expected to grow at a CAGR of 9.1% over the forecast period of 2018-2022, reveals a research report published by Market Research Future (MRFR). The market has observed rapid growth on account of rising prevalence of cardiac disorders such as cardiac arrest, heart failure, artery diseases, stroke. Such cardiac diseases accelerate the demand for medical implants such as Pacemakers, Defibrillators, and Neurostimulators which positively impact the market growth. Growth in incidences of other chronic diseases such as epilepsy and Parkinson's disease also add to market growth.

Segmentation

The global microelectronic medical implants market has been segmented based on product and application. By product, the market has been segmented into neurostimulators, drug infusion pumps, and others. By application, the market has been segmented into pacemakers, defibrillators, neurostimulators, spinal fusion stimulators, implantable drug pumps, hearing implants, eye implants, ocular implants and others.

Regional Analysis

The key markets of the global microelectronic medical implants market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the largest share of the market owing to favorable government policies and growing incidences of cardiac diseases in the region and is expected to grow at a CAGR of 8.7% over the forecast period. Europe follows North America closely and is expected to grow at a CAGR of 8.9% over the forecast period. Asia Pacific is slated to emerge as the fastest growing market owing to the growing healthcare sector and increased medical expenditure in the region. Moreover, the region has a large patient pool which provides growth opportunities in the future.

 

                Competitive Landscape

        The global microelectronic medical implants market is highly competitive and is characterized by the presence of many established players. The key players functioning in the market include Abiomed Inc, Cyberonics Inc., Medtronic Inc., Neuropace Inc., St. Jude Medical Inc., Biomet Inc., Envoy Medical, Microsemi Corporation., Retina Implant AG, Worldheart Corporation and others. The key players are implementing various strategies such as partnership, mergers, acquisition, product launches to sustain their position in the market.

 

        Get Microelectronic Medical Implants Market Information, by Product (Neurostimulators, Drug Infusion Pumps), by Application (Pacemakers, Defibrillators, Neurostimulators, Spinal Fusion Stimulators, Implantable Drug Pumps) - Forecast till 2022   @ https://www.marketresearchfuture.com/reports/microelectronic-medical-implants-market-2370

 

Industry Updates

In April 2018, Chinese orthopedic implant maker AK Medical Holdings Limited acquired JRI Orthopedics Limited, a UK-based orthopedic supplier. The acquisition is a long-term growth initiative and will help the company expand its product portfolio.

In July 2018, a technology group SCHOTT and Primoceler joined forces to produce vacuum-tight, ultra-miniature electronic and optical devices with superior reliability.

 

Related Latest Trending Reports

Bone Densitometers Market Research Report- Forecast to 2022

 

Anti Epilepsy Drugs Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

https://www.marketresearchfuture.com/           

 

]]>
Microelectronic Medical Implants Market 2020 Share Report Analysis, Technology Advancement, Top Companies Tue, 26 May 2020 23:00:02 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640769.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640769.html Market Research Future Market Research Future Market Research Future published a research report on Microelectronic Medical Implants Market Research Report - Global Forecast To 2022 Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

The Microelectronic Medical Implants Market share is expected to grow at a CAGR of 9.1% over the forecast period of 2018-2022, reveals a research report published by Market Research Future (MRFR). The market has observed rapid growth on account of rising prevalence of cardiac disorders such as cardiac arrest, heart failure, artery diseases, stroke. Such cardiac diseases accelerate the demand for medical implants such as Pacemakers, Defibrillators, and Neurostimulators which positively impact the market growth. Growth in incidences of other chronic diseases such as epilepsy and Parkinson's disease also add to market growth.

Segmentation

The global microelectronic medical implants market has been segmented based on product and application. By product, the market has been segmented into neurostimulators, drug infusion pumps, and others. By application, the market has been segmented into pacemakers, defibrillators, neurostimulators, spinal fusion stimulators, implantable drug pumps, hearing implants, eye implants, ocular implants and others.

Regional Analysis

The key markets of the global microelectronic medical implants market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the largest share of the market owing to favorable government policies and growing incidences of cardiac diseases in the region and is expected to grow at a CAGR of 8.7% over the forecast period. Europe follows North America closely and is expected to grow at a CAGR of 8.9% over the forecast period. Asia Pacific is slated to emerge as the fastest growing market owing to the growing healthcare sector and increased medical expenditure in the region. Moreover, the region has a large patient pool which provides growth opportunities in the future.

 

                Competitive Landscape

        The global microelectronic medical implants market is highly competitive and is characterized by the presence of many established players. The key players functioning in the market include Abiomed Inc, Cyberonics Inc., Medtronic Inc., Neuropace Inc., St. Jude Medical Inc., Biomet Inc., Envoy Medical, Microsemi Corporation., Retina Implant AG, Worldheart Corporation and others. The key players are implementing various strategies such as partnership, mergers, acquisition, product launches to sustain their position in the market.

 

        Get Microelectronic Medical Implants Market Information, by Product (Neurostimulators, Drug Infusion Pumps), by Application (Pacemakers, Defibrillators, Neurostimulators, Spinal Fusion Stimulators, Implantable Drug Pumps) - Forecast till 2022   @ https://www.marketresearchfuture.com/reports/microelectronic-medical-implants-market-2370

 

Industry Updates

In April 2018, Chinese orthopedic implant maker AK Medical Holdings Limited acquired JRI Orthopedics Limited, a UK-based orthopedic supplier. The acquisition is a long-term growth initiative and will help the company expand its product portfolio.

In July 2018, a technology group SCHOTT and Primoceler joined forces to produce vacuum-tight, ultra-miniature electronic and optical devices with superior reliability.

 

Related Latest Trending Reports

Bone Densitometers Market Research Report- Forecast to 2022

 

Anti Epilepsy Drugs Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

https://www.marketresearchfuture.com/           

 

]]>
Digestible Sensors Market share 2020 Global Industry Share, Size Estimation, Demand, Trends 2027 Tue, 26 May 2020 22:41:54 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640767.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640767.html Market Research Future Market Research Future Overview

Digestible Sensors are developed with edible materials and consist of a wearable patch. These sensors are activated upon ingestion and transfer medical information about the patients’ health to the respective medical professionals. The transmitted information or medical data helps the physicians to customize the care given to the patient as well as the to other individuals facing similar health conditions or ailments

Market Research Future (MRFR) has launched a new release on the Digestible Sensors Market share Research Report – Forecast to 2027. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period

Global Digestible Sensors Market share– Segmentation

The MRFR analysis is segmented into five key dynamics for the convenience of understanding;

By Product: Strip Sensor, Ingestible Sensor, Invasive Sensors, and Ingestible Sensors, among others

By Application: Diagnostics, Patient Monitoring, and Therapeutics among others.

By Technology: Image, Temperature, Pressure, Biosensors, and Accelerometer among others.

By End-user: Consumer, Pharmaceutical Companies, Healthcare Providers, Sports and Fitness Institutes among others.

By Regions:  North America, Europe, APAC, and the Rest-of-the-World.

Global Digestible Sensors Market – Competitive Analysis
The Global Market of digestible sensors appears to be moderately competitive and consolidated with the limited number of key players operating in the market with the presence of several well-established and small players. Well-established players incorporate acquisition, partnership, collaboration, expansion, and technology launch in order to gain a competitive advantage in this market. Top players invest heavily in R&D and clinical trials to develop effective digestible sensors.

Global Digestible Sensors Research Report: By Product (Strip Sensor, Ingestible Sensor, Invasive Sensors, Others), by Application (Diagnostics, Patient Monitoring, Therapeutics), by Technology (Image, Temperature, Others), by End-User – Forecast Till 2027
The Global Digestible Sensors Market is driven by some of the prominent players including Freescale Semiconductor, Inc., Proteus Digital Health, Philips Healthcare, Analog Devices, Inc., STMicroelectronics, GE Healthcare, Measurement Specialties, Honeywell International, Medtronic Plc, Smiths Medical, and Sensirion AG among others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
HTS Market industry Overview by Top Companies Analysis, Upcoming Trends, Emerging Growth Tue, 26 May 2020 22:27:16 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640765.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640765.html Market Research Future Market Research Future Market Research Future published a research report high throughput screening instrument market size Research Report – Global Forecast till 2025– Market Overview, Segmentation, Progress, Regional analysis, key Trends, Major Players and Forecast to 2025. Global Wearable Sensors Market is likely to value of USD 13,460 million with a CAGR of 7.5% during the forecast period

get free sample copy @ https://www.marketresearchfuture.com/sample_request/1280

Competitive Landscape:

Better integration of diverse plans in the global high throughput screening market and introduction of several strategic moves that encompasses mergers, acquisitions, tie-ups, and others are expected to inspire growth. Companies impacting the growth in the market are Danaher (US), Aurora Biomed Inc. (Canada), Tecan (Switzerland), PerkinElmer (US), Axxam (Italy), Hamilton (US), Corning (US), Merck Group (Germany), Beckman Coulter, Inc. (US), BioTek (US), Luminex Corporation (US), Agilent Technologies Inc. (US), and Roche (Switzerland).

Overview

High-throughput screening (HTS) can be defined as a method that includes scientific experimentation needed for various drug discovery and deciding typical moves in the the fields of biology and chemistry. The procedure includes data processing/control software, liquid handling devices, robotics, and sensitive detectors. This allows the system to get into the procedure of conducting tests for millions of chemical, genetic, or pharmacological processes. The process has evolved as necessary to find active compounds, antibodies, or genes that can cover various biomolecular pathway. This process assists in the designing of various market process.

The high throughput screening (hts) market is getting traction from high technological advancements in HTS and hike in expenditure for research and development. The government funding for the procedure is also providing better scope for growth.

Segmental Analysis

The global market for high throughput screening, by product & service, can be segmented into instruments, reagents & assay kits, consumables & accessories, and software and services. The reagents & assay kits segment can find growth with increasing demand from the diagnostic segment.

By technology, the global market report on high throughput screening can be segmented into cell-based assays, Bioinformatics, 3D cell culture, 2D cell culture, perfusion cell culture, 3D cell culture, Ultra-high-throughput Screening, lab-on-a-chip (LOC), and Label-free Technology. The 3D cell culture segment includes scaffold-based technologies and scaffold-free technologies. The scaffold-based segment comprises hydrogels, inert matrix, and micropatterned surfaces. The scaffold-free technologies segment consists ultra-low binding plates, hanging-drop plates, microplate, and other scaffold-free technologies.

By application, the global market for high throughput screening includes primary and secondary screening, toxicology assessment, target identification & validation, and others. The application segment is showing signs of fastest CAGR owing to its inclusion in the research and development sector.

By end user, the global market for high throughput screening can be segmented into contract research organizations, academic & government institutes, pharmaceutical & biotechnology companies, and others.

Global High Throughput Screening Market Research Report- https://www.marketresearchfuture.com/reports/high-throughput-screening-market-1280

In October 2019, researchers at Sanford Burnham Prebys Medical Discovery Institute revealed that they have developed a machine-learning algorithm that would assist in the high throughput screening of epigenetic drugs.

Related News

Blood Glucose Monitoring Market – Global Forecast till 2023

Dercum’s Disease Market – Global Forecast till 2023

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

https://www.marketresearchfuture.com

]]>
Musculoskeletal System Disorders Market Trends 2020, Share, Trends, Growth Factors, Segments and Geographic Overview Tue, 26 May 2020 22:19:17 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640764.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640764.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of ~5.30% during the forecast period of 2019 to 2025 and was valued at USD 3837.7 million in 2018.

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/8232

Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck.

The growth of global Musculoskeletal System Disorders Market trends is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are   expected to curb the growth of the global musculoskeletal system disorders market.

The global musculoskeletal system disorders market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of musculoskeletal system disorders and rising per capita healthcare expenditure. The musculoskeletal system disorders market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European musculoskeletal system disorders market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The musculoskeletal system disorders market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of musculoskeletal system disorders and rising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The musculoskeletal system disorders market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

Some of the key players in the global musculoskeletal system disorders market are AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan),  AstraZeneca (UK), Baxter (US), and GlaxoSmithKline PLC (UK).

Access Report Details @ https://www.marketresearchfuture.com/reports/musculoskeletal-system-disorders-market-8232

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Musculoskeletal System Disorders Market Trends 2020, Share, Trends, Growth Factors, Segments and Geographic Overview Tue, 26 May 2020 22:14:05 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640762.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640762.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of ~5.30% during the forecast period of 2019 to 2025 and was valued at USD 3837.7 million in 2018.

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/8232

Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck.

The growth of global Musculoskeletal System Disorders Market trends is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are   expected to curb the growth of the global musculoskeletal system disorders market.

The global musculoskeletal system disorders market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of musculoskeletal system disorders and rising per capita healthcare expenditure. The musculoskeletal system disorders market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European musculoskeletal system disorders market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The musculoskeletal system disorders market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of musculoskeletal system disorders and rising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The musculoskeletal system disorders market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

Some of the key players in the global musculoskeletal system disorders market are AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan),  AstraZeneca (UK), Baxter (US), and GlaxoSmithKline PLC (UK).

Access Report Details @ https://www.marketresearchfuture.com/reports/musculoskeletal-system-disorders-market-8232

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Bipolar Disorders Treatment Market share, Size Analysis Statistics 2020 by Key Driving Factor, Dazzling Growth Tue, 26 May 2020 22:02:42 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640761.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640761.html Market Research Future Market Research Future Global Bipolar Disorders Treatment Market Research Report: Information by Drug Type (Mood Stabilizer, Anticonvulsant, Antipsychotic Drug, and Antidepressant Drug), Mechanism of Action (Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitor, Monoamine Oxidase Inhibitors, Beta Blockers, and Tricyclic Antidepressant Drug), End User (Hospitals and Clinics, Multispecialty Centers, and Others), and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2025

Get free sample copy @ https://www.marketresearchfuture.com/sample_request/1566

Global Bipolar Disorders and Treatment Market   - Overview

The Bipolar Disorders Treatment Market share is growing with the rapid pace; mainly due to the increasing stress in life. According to a recent study report published by the Market Research Future, The global bipolar disorders and treatment market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).  

Bipolar disorder, called manic depression, which is a mental health condition that causes extreme mood swings includes emotional highs (mania or hypomania) and lows (depression). There are several types of bipolar disorder which includes bipolar I disorder, bipolar II disorder and others. Bipolar I is considered by one or more manic episodes or mixed episodes. Typically a person will experience periods of depression as well. Moreover, bipolar I disorder is marked by extreme manic episodes. Bipolar II disorder are generally diagnosed after one or more major depressive episodes and at least one episode of hypomania, with possible periods of level mood between episodes.

 Global Bipolar Disorders and Treatment Market   - Competitive Analysis

AstraZeneca (U.K), Bristol-Myers Squibb (U.S), Eli Lilly and Company (U.S), GlaxoSmithKline PLC (U.K), Allergan (U.S), Janssen Pharmaceuticals (Belgium), Dainippon Sumitomo Pharma Co., Ltd (Japan), Lundbeck (Denmark), Abbott (U.S.), Cephalon Inc. (Teva Phamaceuticals), Dainippon Sumitomo Pharma Co. Ltd., Forest Laboratories Inc. (U.S.), Gedeon Richter PLC (Hungary), Otsuka America Pharmaceutical Inc., (U.S.) Repligen Corporation, (U.S.) and Pfizer Inc. (U.S.)  are some of the prominent players at the forefront of competition in the Global Bipolar Disorders and Treatment Market and are profiled in MRFR Analysis. 

July, 2017- Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced ABILIFY MAINTENA (Aripiprazole) injectable suspension whcih is approved by U.S. FDA for maintenance monotherapy treatment of Bipolar I disorder. According to otsuka company reports ABILIFY MAINTENA is a once a monthly injectable formulation for intramuscular and has been co-developed and co-commercialized with Lundbeck. Based on Phase 3 study data, ABILIFY MAINTENA delayed the time to recurrence of any mood episode in adult patients experiencing a manic episode at screening compared to placebo.

Global Bipolar Disorders and Treatment Market   - Regional Analysis

North America dominates the global bipolar disorder and treatment market owing to increased awareness about bipolar disorder in the region and presence of major market players. The U.S. represents the largest market for bipolar disorder followed by Canada in North America region.

According to the National Institute of Mental Health (NIMH), bipolar disorder affects more than 5.7 million adults (about 3 % of the population) in the United States each year. The typical age is the late teens or early 20s, and a history of depression is common in people diagnosed with bipolar.

Access Report Details @ https://www.marketresearchfuture.com/reports/bipolar-disorders-treatment-market-1566

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Gruppo Tempocasa sigla una partnership con Indeed Tue, 26 May 2020 21:54:53 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640759.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640759.html Press Way Press Way Tempocasa, leader nell’intermediazione immobiliare, continua a puntare sulle risorse umane e sigla un accordo con Indeed, prima piattaforma di recruitment al mondo nell'ambito digitale. 

 

Grazie all’accordo, il Gruppo Tempocasa, con le sue oltre 430 agenzie, diventa il primo gruppo immobiliare a centralizzare la ricerca del personale attraverso un’unica piattaforma, leader di mercato.

 

In un momento sfidante come quello attuale, l’azienda punta con determinazione sulla qualità e sulla professionalità delle proprie risorse: solo nel nord Italia, dopo aver reclutato oltre 400 collaboratori nel 2019, Tempocasa prevede di raggiungere altri 400 nuovi inserimenti entro la fine del 2020, centralizzando le nuove ricerche attraverso la sua pagina ufficiale sul portale Indeed. 

 

Valerio Vacca, direttore della comunicazione Tempocasa, spiega: “In un momento storico come quello attuale, è fondamentale differenziarci dalla concorrenza offrendo al cliente un servizio sempre più qualitativo. Questo è possibile selezionando persone determinate, ambiziose, appassionate, che credono nel lavoro di squadra. La partnership con Indeed ci consente di utilizzare strumenti evoluti per le nostre ricerche di personale, allineando l’intero network di agenzie sul territorio agli standard qualitativi della casa madre, e ci consente di lavorare sull'employer branding”.

 

Dario D'Odorico, Director di Indeed.com ha dichiarato: "La nostra missione è di aiutare le persone a trovare lavoro. In quanto sito numero uno in Italia per la ricerca di lavoro, con oltre 10 milioni di viste al mese, sappiamo quanto sia importante trovare il talento giusto. Siamo felici di poter aiutare Tempocasa nella loro missione di assumere i migliori candidati per far crescere il loro business in questo periodo così complesso".

]]>
Gruppo Tempocasa sigla una partnership con Indeed Tue, 26 May 2020 21:54:30 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640758.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640758.html Press Way Press Way Tempocasa, leader nell’intermediazione immobiliare, continua a puntare sulle risorse umane e sigla un accordo con Indeed, prima piattaforma di recruitment al mondo nell'ambito digitale. 

 

Grazie all’accordo, il Gruppo Tempocasa, con le sue oltre 430 agenzie, diventa il primo gruppo immobiliare a centralizzare la ricerca del personale attraverso un’unica piattaforma, leader di mercato.

 

In un momento sfidante come quello attuale, l’azienda punta con determinazione sulla qualità e sulla professionalità delle proprie risorse: solo nel nord Italia, dopo aver reclutato oltre 400 collaboratori nel 2019, Tempocasa prevede di raggiungere altri 400 nuovi inserimenti entro la fine del 2020, centralizzando le nuove ricerche attraverso la sua pagina ufficiale sul portale Indeed. 

 

Valerio Vacca, direttore della comunicazione Tempocasa, spiega: “In un momento storico come quello attuale, è fondamentale differenziarci dalla concorrenza offrendo al cliente un servizio sempre più qualitativo. Questo è possibile selezionando persone determinate, ambiziose, appassionate, che credono nel lavoro di squadra. La partnership con Indeed ci consente di utilizzare strumenti evoluti per le nostre ricerche di personale, allineando l’intero network di agenzie sul territorio agli standard qualitativi della casa madre, e ci consente di lavorare sull'employer branding”.

 

Dario D'Odorico, Director di Indeed.com ha dichiarato: "La nostra missione è di aiutare le persone a trovare lavoro. In quanto sito numero uno in Italia per la ricerca di lavoro, con oltre 10 milioni di viste al mese, sappiamo quanto sia importante trovare il talento giusto. Siamo felici di poter aiutare Tempocasa nella loro missione di assumere i migliori candidati per far crescere il loro business in questo periodo così complesso".

]]>
Alpha-1 Antitrypsin Deficiency Treatment Market share2020 Analysis Devices, By Top Key Players, Global Industry Size Tue, 26 May 2020 21:50:46 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640757.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640757.html Market Research Future Market Research Future Market Forecast

Registering a CAGR of 10.50%, the Global Alpha-1 Antitrypsin Deficiency Treatment Market is expected to grow from USD 1,464.1 Million in 2018 to USD 2,914.7 Million by 2025.

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/8319

As of July 2019, 3.4 million people are affected by alpha-1 antitrypsin deficiency worldwide. The disorder is found to affect populations in all the regions of the world.

Segmentation

By Drugs:

  • Alpha-1 Proteinase Inhibitor: The segment is expected to hold the largest market share as it is the only treatment for AATD, which protects the patient from more lung damage.
  • Bronchodilators: These are used for the treatment of respiratory disorders associated with AATD.
  • Steroids: These are used specifically for the treatment of chronic obstructive pulmonary disease, which affects the patient along with AATD.
  • Others: Other treatment options include antibiotics for infections and jaundice associated with AATD and oxygen therapy.

By Route of Administration:

  • Oral: The segment is expected to hold the largest market share.
  • Intravenous: The segment is expected to grow at the fastest CAGR.
  • Inhalation: This route of administration is used specifically for the administration of corticosteroids for treating breathing disorders.
  • Others: Subcutaneous and intramuscular routes of administration.

By Distribution Channel:

  • Hospital Pharmacy: The rise in the number of hospitals is likely to be responsible for the largest Alpha-1 Antitrypsin Deficiency Treatment Market share size.
  • Retail Pharmacy: These fulfill the requirement of drugs that are needed for treatment at home.
  • Online Stores: The fastest-growing segment owing to increase in number of online pharmacies.

Key Players

  • Kamada Pharmaceuticals (Israel)
  • CSL Behring LLC (US)
  • Grifols, S.A. (Spain)
  • Takeda Pharmaceutical Company Limited (Japan)
  • GlaxoSmithKline plc (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca (UK)
  • Vectura Group plc (UK)
  • Pfizer Inc. (US)
  • Mylan Inc. (US)

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/alpha-1-antitrypsin-deficiency-treatment-market-8319

 Key Players

  • Kamada Pharmaceuticals (Israel)
  • CSL Behring LLC (US)
  • Grifols, S.A. (Spain)
  • Takeda Pharmaceutical Company Limited (Japan)
  • GlaxoSmithKline plc (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca (UK)
  • Vectura Group plc (UK)
  • Pfizer Inc. (US)
  • Mylan Inc. (US)

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Hearing Aids Market Share Industry Analysis, Share, Trends and Forecast to 2023 Tue, 26 May 2020 21:38:10 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640756.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640756.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, the global hearing aids market is expected to register a CAGR of ~7% during the forecast period of 2019 to 2025 and was valued at USD 8 billion in 2018.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8364

A hearing aid is an electronic device which amplifies sound so that a person with hearing loss can listen, participate in daily activities, and communicate with others. The three basic parts of a hearing aid are a speaker, an amplifier, and a microphone.

Segmentation

The global Hearing Aids Market share has been segmented based on product, product type, type of hearing loss, technology type, and distribution channel.

The market, based on product, has been divided into devices, implants, and accessories, out of which implants is the fastest-growing segment. For instance, the Australia-based manufacturer Cochlear Ltd reported a profit of USD 265 to USD 275 million in first quarter of 2019, 8% to 12% more as compared to that in the first quarter of 2018.

The global hearing aids market has been segmented, on the basis of product type, into wired and wireless. Wireless is the fastest-growing segment owing to technological advancements and product launches. For instance, Sonova, in November 2018 launched products based on SWORD (Sonova Wireless One Radio Digital) chip. The new technology allows hearing instruments to connect with electronic devices such as televisions or mobile phones.

The type of hearing loss segments of the market are sensorineural, conductive, and others. The growth of the segment is due to the high prevalence of hearing loss. For instance, in 2018, around 2 to 3 out of 1000, children in the US are born with a hearing loss in one or both ears.

The technology type segment of the market is segmented as digital hearing aids and analog hearing aids. The digital hearing aids segment is expected to be both, the largest shareholder and the fastest-growing segment owing to its advantages over analog counterparts.

The distribution channel segment is classified into retail stores, E-commerce, and others. The E-commerce segment is expected to be the fastest-growing segment owing to ease of access to products for customers.

Key Players

Some of the key players in the global hearing aids market are Sonova (Switzerland), Cochlear Ltd. (Australia), GN Store Nord A/S (Denmark), Sivantos Pte. Ltd. (Singapore), Arphi Electronics Private Limited (India), Demant A/S (Denmark), Starkey (US), WIDEX INDIA PRIVATE LIMITED (Denmark), Zounds Hearing (US), SeboTek Hearing Systems, LLC (US), Audina Hearing Instruments, Inc. (US), and Microson (Spain).

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hearing-aids-market-8364

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

 

]]>
Non-Invasive Prenatal Testing (NIPT) Market share Analysis 2023 by Size, Trends, Share, Growth and Segmental Overview Tue, 26 May 2020 21:28:42 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640754.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640754.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8371

NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.

Key Players

Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd

 Segmentation

The global Non-Invasive Prenatal Testing (NIPT) Market share has been segmented based on product type, techniques, application, and end user.

The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.

The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.

On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.

The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.

Access Report Details @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Behavioral Health Services Market Forecast 2023 Analysis Overview by Top Companies Analysis, Upcoming Trends Tue, 26 May 2020 21:17:06 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640753.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640753.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, Behavioral Health Services Market is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025.

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/8433

Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from behavioral health issues. According to Japanese study around 298 people were suffering from various behavioral disorders in 2018. The growth of the global behavioral health services market is driven by various factors such as an increasing global geriatric population, rising prevalence of the depressive disorder, and poor fitness levels. However, high costs of treatment are expected to curb the growth of the global behavioral health services market.

The Global Behavioral Health Services Market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Segmentation

The Global Behavioral Health Services Market Forecast has been segmented based on services type, disorder type, and end user.

The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others. The inpatient hospital treatment segment is likely to be the largest during the review period due to a growing aging population globally. Around 1.3 million Americans are diagnosed with various behavioral disorders every year. The outpatient counseling segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population.  

The global behavioral health services market has been segmented on the basis of disorder type, into anxiety disorder, bipolar disorders, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder, and others.  The anxiety disorder segment is expected to hold the majority share of the market. Rising prevalence of anxiety disorder in most commonly seen in US. Around 40 million adults are diagnosed with anxiety disorder every year. The bipolar disorder segment is expected to be the fastest-growing due to its rising prevalence globally. It was estimated that around 7 million people in US were suffering through bipolar disorder in 2018.

The end user segments of the market are providers, patients, and others. The providers segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services.

Key Players

Some of the key players in the global Behavioral Health Services market are Acadia Healthcare (US), National Mentor Holdings Inc (US), Behavioral Health Services Inc (US), Ocean Mental Health Services Inc (US), The MENTOR Network (US), Universal Health Services, Inc (US),  Behavioral Health Network, Inc (US), CareTech Holdings PLC (UK), Strategic Behavioral Health (US), North Range Behavioral Health (US), Pyramid Healthcare (US), Promises Behavioral Health (US), and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/behavioral-health-services-market-8433

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.


 

]]>
Biopharmaceuticals Market Trends by Top Companies Analysis, Upcoming Trends, Emerging Growth, Segments and Forecast to 2023 Tue, 26 May 2020 20:10:05 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640748.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640748.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8439

Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells.

Segmentation

The global Biopharmaceuticals Market trends has been segmented based on product type and application.

The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases.

Key Players

Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Lymphedema Treatment Market Trends | Worldwide Overview by Size, Share, Trends, Tue, 26 May 2020 18:53:53 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640740.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640740.html Market Research Future Market Research Future Market Synopsis

The increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.

The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million.

Market Drivers

  • Increasing cancer cases

Lymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.

It is reported that a majority of the lymphedema cases affect cancer patients. The condition can arise immediately after cancer surgery or radiation therapy. However, in certain cases, lymphedema is reported after months or years of cancer treatment. Thus, it is projected that the global lymphedema treatment market will grow, parallelly, to the increasing prevalence of cancer.

  • Favorable reimbursement policies
  • Strong pipeline in the market
  • Government support

Segmentation

By Type

  • Primary Lymphedema is caused by the abnormal development of the lymph system. Symptoms may occur at birth or older age. The primary lymphedema segment is estimated to hold the least Lymphedema Treatment Market Trends share in 2018.

  • Secondary Lymphedema is caused by damage to the lymph system owing to cancer treatment involving surgery, radiation therapy, and others. A majority of the patients suffered from secondary lymphedema making this the leading segment in 2018.

By Affected Area

  • Lower Extremity: Lower extremity lymphedema involves the swelling of ankles, legs, and feet. This segment is estimated to hold a share of 0% in 2018.

  • Upper Extremity: Upper extremity lymphedema is one of the most poorly understood complications of the disease, making the segment to hold a share of 9.0% in the market in 2018.

  • Genitalia: This segment held the least share of the market in 2018.

By Treatment

  • Compression Devices & Bandaging: Compression devices are pumps connected to a sleeve that is then wrapped around the affected area that applies pressure. This helps the fluids to circulate through the lymph vessels and veins.

  • Bandaging involves wrapping, thereby helping in preventing the area from refilling with fluid. Lymphedema that has not improved with other treatments can be treated with bandaging. Thus, compression devices & bandaging segment was the largest segment of the lymphedema treatment market in 2018.

  • Laser Therapy: Laser therapy reduces lymphedema swelling after a mastectomy. The segment is estimated to be one of the fastest-growing segments.

  • Drug Therapy & Surgery: Drug therapy and surgery are the least opted treatment in the market, making the segment to hold the least share in the market.

  • Key Players
    • 3A Health Care (Italy)
    • Bio Compression Systems, Inc. (US)
    • Devon Medical Products (US)
    • HERANTIS PHARMA PLC (Finland)
    • Lohmann & Rauscher (Germany)
    • Mego Afek Ltd (US)
    • SIGVARIS (Switzerland)
    • Tactile Systems Technology Inc. (US)
    • Wright Therapy Products (BSN Medical) (Germany)

      About Market Research Future:

      At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

       

]]>
Stem Cell Banking Market 2020 | Size, Share, Growth, Industrial Analysis Tue, 26 May 2020 18:28:39 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640734.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640734.html Market Research Future Market Research Future Market Highlights

According to MRFR analysis, Stem Cell Banking Market is expected to register a CAGR of 9.8% during the forecast period of 2019 to 2025 and is expected to reach USD 12,056.7 Million by 2025.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8441

Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth. The stem has the potential to develop into several different cell types, from muscle cells to brain cells

Segmentation

The Global Stem Cell Banking Market Growth has been segmented based on cell type, bank type, and application.

Based on cell type, the market has been divided into umbilical cord stem cells, adult stem cells, and embryonic stem cells. The umbilical cord stem cells segment has been additionally categorized into cord blood, cord tissue, and placenta. The umbilical cord stem cells segment will hold the highest market share over the forecast period due to huge demand for umbilical cord blood in stem cell research. Scientists found that the umbilical cord is a rich source of stem cells and are collected from people of different biological traits.

On the basis of bank type, the global stem cell banking market has been classified into private banks, public banks, and hybrid banks. The private bank's segment would lead the market throughout the forecast period as it generates greater revenue, the cost to retrieve cord blood is free, and has complete ownership rights preserved by the donor. In addition, private banks have flexible collection sites and assured, and secured access offers a competitive advantage over public banks.

By application, the market has been bifurcated into thalassemia, cerebral palsy, diabetes, leukemia, autism, and others. The diabetes segment is likely to witness the fastest market growth due to the rising burden of diabetes mellitus (DM) across the world, thereby augmenting the demand for stem cells. For instance, as per statistics published by the International Diabetes Federation (IDF), in 2017, about 425 million adults were living with diabetes worldwide, which is anticipated to increase to 629 million by 2045.

Key Players

Some of the key players in the Global Stem Cell Banking Market are Americord Registry LLC (US), CBR Systems, Inc. (US), Cryo-Cell International, Inc. (US), Cordlife (Singapore), Cryo-Save AG (Netherlands), Smart Cells International Ltd. (UK), Global Cord Blood Corporation (Hong Kong), Celgene Corporation (US), BrainStorm Cell Therapeutics (US), and Regrow Biosciences Pvt. Ltd. (India).

Access Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-banking-market-8441

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

]]>
Global Hybrid Fiber Coaxial Market Report – Impact Of Covid-19 And Benchmarking Tue, 26 May 2020 18:04:05 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640728.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640728.html industrynews industrynews The Hybrid Fiber Coaxial Market research report provides the latest industry data, growth, key segments and future trends on the basis of  the detailed study. Moreover, this market report also allowing you to identify the opportunity and growth rate of the leading segment, revenue growth and profitability.

The study offers a decisive view of the global hybrid fiber coaxial market by segmenting it in terms of technology, component, and application. The report analyzes these subsets with respect to the regional segmentation. This research study will prepare marketers for the evolving needs of their customers.

Request a FREE Sample Copy of Global Hybrid Fiber Coaxial Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/hybrid-fiber-coaxial-market/download-sample

By Technology

·       DOCSIS 3.0 & Below

·       DOCSIS 3.1

By Component

·       Transceiver

·       Splitter

·       Amplifier

·       Modulator

·       Encoder

·       RF Combiner

·       Optical Node

·       Fiber Optic Cable

·       Coaxial/Copper Cable

By Application

·       Digital TV

·       Broadband

This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global hybrid fiber coaxial market are Assia, Inc., Ciena Corp., Cisco Systems, Inc., Comcast Corp., CommScope, Inc., Corning, Inc., PCT International, Inc., Shanghai Tarluz Telecom Tech. Co., Ltd., Skyworks Solutions, Inc., Teleste Corp., and Telstra Corp., and others. This section cover profiling of major players in terms of important aspects such as company overview, financial overview, business strategy, and recent developments undertaken during the forecast horizon.

This section covers hybrid fiber coaxial market for the regions North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional segmentation has been done based on the present and future trends in the global hybrid fiber coaxial market along with the individual application segment across all the prominent region.

Browse Full Global Hybrid Fiber Coaxial Market Research Report With TOC At: https://www.valuemarketresearch.com/report/hybrid-fiber-coaxial-market

About Us:

Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.

We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:

Value Market Research

401/402, TFM, Nagras Road, Aundh, Pune-7.

Maharashtra, INDIA.

Tel: +1-888-294-1147

Email: sales@valuemarketresearch.com

Website: https://www.valuemarketresearch.com

]]>
Impact of COVID-19 Hydraulic Breakers Market 2020 - Overview By Industry Trends, Growth Factor and Analysis To 2026 Tue, 26 May 2020 18:02:58 +0200 http://zend.comunicati.net/comunicati/aziende/tecnologia/640727.html http://zend.comunicati.net/comunicati/aziende/tecnologia/640727.html industrynews industrynews The Hydraulic Breakers Market research report provides the latest industry data, growth, key segments and future trends on the basis of  the detailed study. Moreover, this market report also allowing you to identify the opportunity and growth rate of the leading segment, revenue growth and profitability.

The study offers a decisive view of the global hydraulic breakers market by segmenting it in terms of type and application. The report analyzes these subsets with respect to the regional segmentation. This research study will prepare marketers for the evolving needs of their customers.

Request a FREE Sample Copy of Global Hydraulic Breakers Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/hydraulic-breakers-market/download-sample

By Type

·       Small and Medium Range

·       Large Range

By Application

·       Mining Industry

·       Construction Industry

This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global hydraulic breakers market are Atlas Copco, Boart Longyear, Caterpillar, Komatsu, and Sandvik. This section cover profiling of major players in terms of important aspects such as company overview, financial overview, business strategy, and recent developments undertaken during the forecast horizon.

This section covers hydraulic breakers market for the regions North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional segmentation has been done based on the present and future trends in the global hydraulic breakers market along with the individual application segment across all the prominent region.

Browse Full Global Hydraulic Breakers Market Research Report With TOC At: https://www.valuemarketresearch.com/report/hydraulic-breakers-market

About Us:

Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.

We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:

Value Market Research

401/402, TFM, Nagras Road, Aundh, Pune-7.

Maharashtra, INDIA.

Tel: +1-888-294-1147

Email: sales@valuemarketresearch.com

Website: https://www.valuemarketresearch.com

]]>